212 related articles for article (PubMed ID: 12460198)
1. Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy.
Grönlund H; Vrtala S; Wiedermann U; Dekan G; Kraft D; Valenta R; Van Hage-Hamsten M
Immunology; 2002 Dec; 107(4):523-9. PubMed ID: 12460198
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
3. Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.
Mothes N; Heinzkill M; Drachenberg KJ; Sperr WR; Krauth MT; Majlesi Y; Semper H; Valent P; Niederberger V; Kraft D; Valenta R
Clin Exp Allergy; 2003 Sep; 33(9):1198-208. PubMed ID: 12956739
[TBL] [Abstract][Full Text] [Related]
4. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
5. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study.
Klimek L; Schendzielorz P; Pinol R; Pfaar O
Clin Exp Allergy; 2012 Jun; 42(6):936-45. PubMed ID: 22909165
[TBL] [Abstract][Full Text] [Related]
6. Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.
Hessenberger M; Weiss R; Weinberger EE; Boehler C; Thalhamer J; Scheiblhofer S
Vaccine; 2013 Jul; 31(34):3427-34. PubMed ID: 23273971
[TBL] [Abstract][Full Text] [Related]
7. Allergens. Heterogeneity of molecular sensitization profiles in grass pollen allergy--implications for immunotherapy?
Darsow U; Brockow K; Pfab F; Jakob T; Petersson CJ; Borres MP; Ring J; Behrendt H; Huss-Marp J
Clin Exp Allergy; 2014; 44(5):778-86. PubMed ID: 24598010
[TBL] [Abstract][Full Text] [Related]
8. Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.
Ball T; Sperr WR; Valent P; Lidholm J; Spitzauer S; Ebner C; Kraft D; Valenta R
Eur J Immunol; 1999 Jun; 29(6):2026-36. PubMed ID: 10382766
[TBL] [Abstract][Full Text] [Related]
9. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation.
Vrtala S; Ball T; Spitzauer S; Pandjaitan B; Suphioglu C; Knox B; Sperr WR; Valent P; Kraft D; Valenta R
J Immunol; 1998 Jun; 160(12):6137-44. PubMed ID: 9637531
[TBL] [Abstract][Full Text] [Related]
10. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen.
Ebner C; Siemann U; Bohle B; Willheim M; Wiedermann U; Schenk S; Klotz F; Ebner H; Kraft D; Scheiner O
Clin Exp Allergy; 1997 Sep; 27(9):1007-15. PubMed ID: 9678832
[TBL] [Abstract][Full Text] [Related]
11. Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB/c mice.
Pali-Schöll I; Szöllösi H; Starkl P; Scheicher B; Stremnitzer C; Hofmeister A; Roth-Walter F; Lukschal A; Diesner SC; Zimmer A; Jensen-Jarolim E
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):656-64. PubMed ID: 23523543
[TBL] [Abstract][Full Text] [Related]
12. IgE profiles of Bermuda grass pollen sensitised patients evaluated by Phleum pratense allergens Phl P 1, 2, 4, 5, 6 , 7, 11, 12.
Rossi RE; Monasterolo G; Prina P; Coco G; Operti D; Rossi L
Allergol Int; 2008 Jun; 57(2):157-64. PubMed ID: 18349590
[TBL] [Abstract][Full Text] [Related]
13. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
[TBL] [Abstract][Full Text] [Related]
14. Immunostimulatory oligodeoxynucleotide induces TH1 immune response and inhibition of IgE antibody production to cedar pollen allergens in mice.
Kohama Y; Akizuki O; Hagihara K; Yamada E; Yamamoto H
J Allergy Clin Immunol; 1999 Dec; 104(6):1231-8. PubMed ID: 10589006
[TBL] [Abstract][Full Text] [Related]
15. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.
Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS
Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651
[TBL] [Abstract][Full Text] [Related]
16. Immunoprophylaxis with DNA vaccination inhibits Th2-mediated responses and airway inflammation in mice sensitised with the major timothy grass pollen allergen Phl p 5b.
Darcan Y; Petersen A; Becker WM; Galle J; Ernst M; Ahmed J; Seitzer U
Vaccine; 2005 Jul; 23(33):4203-11. PubMed ID: 15904999
[TBL] [Abstract][Full Text] [Related]
17. Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells.
Wilcock LK; Francis JN; Durham SR
Clin Exp Allergy; 2004 Sep; 34(9):1373-8. PubMed ID: 15347369
[TBL] [Abstract][Full Text] [Related]
18. "Allergen engineering": variants of the timothy grass pollen allergen Phl p 5b with reduced IgE-binding capacity but conserved T cell reactivity.
Schramm G; Kahlert H; Suck R; Weber B; Stüwe HT; Müller WD; Bufe A; Becker WM; Schlaak MW; Jäger L; Cromwell O; Fiebig H
J Immunol; 1999 Feb; 162(4):2406-14. PubMed ID: 9973522
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of mice with olive pollen allergen Ole e 1 induces a Th2 response.
Batanero E; Barral P; Villalba M; Rodríguez R
Int Arch Allergy Immunol; 2002 Apr; 127(4):269-75. PubMed ID: 12021545
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
